Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL

Area of Science:

• Lipid metabolism
• Endothelial cell biology
• Vascular health

Background:

• Nephrotic syndrome is associated with defective binding of very low-density lipoprotein (VLDL) to endothelial cells.
• It remains unclear if this defect is inherent to nascent VLDL (nVLDL) or acquired post-secretion.
• This study investigates whether high-density lipoprotein (HDL) confers the binding defect to VLDL.

Purpose of the Study:

• To determine if VLDL is normal at secretion and acquires defects through interaction with HDL.
• To investigate the role of HDL in conferring endothelial binding and lipolysis defects to VLDL.

Main Methods:

• Isolated perfused livers from control and nephrotic rats synthesized and secreted nVLDL.
• nVLDL was labeled to assess binding, apolipoprotein exchange, and composition.
• nVLDL was incubated with HDL from control or nephrotic rats to evaluate defect conferral.
• Lipoprotein lipase-mediated lipolysis and apolipoprotein E (apoE) content were analyzed.

Main Results:

• Nephrotic nVLDL exhibited greater endothelial binding and lipolysis compared to control nVLDL.
• Incubation with nephrotic HDL reduced nVLDL binding and lipolysis, irrespective of nVLDL source.
• Nephrotic HDL showed reduced apoE/apoA-I ratio, and reintroducing apoE to nephrotic VLDL restored binding.

Conclusions:

• The endothelial binding and lipolysis defects in VLDL from nephrotic rats are acquired post-secretion, conferred by HDL.
• Nephrotic HDL may fail to enrich VLDL with apoE, leading to impaired VLDL function.
• These findings highlight HDL's role in modulating VLDL-endothelial interactions in nephrotic conditions.